Lautman Foundation appeared to be the VC, which was created in 2008.
The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Shmuel Kabili, Fischer Pharmaceutical Laboratories Ltd, Fidelity Ventures. In the next rounds fund is usually obtained by Yelin Lapidot Investment House, ROTH Capital Partners, OrbiMed.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2010. The increased amount of exits for fund were in 2013.
The current fund was established by Noam Lautman.
Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight RedHill Biopharma. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology.
Related Funds
| Fund Name | Location |
| Alpen Route Asset Management | Seoul, Seoul-t'ukpyolsi, South Korea |
| Asian asset management | - |
| Chilin Venture Capital | - |
| CIT VentureCapital | Morristown, New Jersey, United States |
| Daoyitong | Beijing, Beijing, China |
| Delaware Crossing Investor Group | Doylestown, Pennsylvania, United States |
| Harmonic Growth Partners | Chevy Chase, Maryland, United States |
| INNOVISION | China, Guangdong, Guangzhou |
| McKinney | Durham, North Carolina, United States |
| Tiempo | France, Montbonnot-saint-martin, Rhone-Alpes |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 